HEK 293 cells have a low basal expression of MAGEB2. Patient-derived cancer cell lines such as HCT116 (colon cancer) and SK-MEL-2 (melanoma) displayed a 6–8-fold higher expression of MAGEB2 (Figure 1C). This evidence concerns the gene MAGEB2 and colonic neoplasm.